# Anti-Invasion Effects of Cannabinoids on Breast Cancer Stem Cells > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoids-breast-cancer-stem-cells-anti-invasion-effects/ > **Published:** 2021-12-21T15:48:48-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:16:49-04:00 > **Clinical Summary:** Explore cannabinoids breast cancer stem cells and their anti-invasion effects on tumor metastasis and cancer stem cell invasiveness. --- In most types of solid tumors, the metastasis of invasive tumor cells from their origin to different organs throughout the body is often lethal to patients. Recent research has uncovered the crucial role of cancer stem cells (CSC) in tumor metastasis and drug resistance. CSCs account for a tiny subpopulation of tumor cells – only 0.1-1% – but have self-protecting, apoptosis (cell death) evading, long living properties as well as the deadly capability to give rise to multiple lineages of tumorous cells. Meanwhile, conventional cancer therapies like chemotherapy and radiotherapy often only inhibit tumor growth temporarily while lacking efficacy in eradicating CSCs. Hence, CSCs are a critical target in oncology. Because the anti-neoplastic activity of cannabinoids has been documented in breast cancer cells robustly, scientists at the University of Tehran, Tehran, Iran recently investigated this effect against breast cancer stem cells. They evaluated 2 [synthetic cannabinoids](https://cedclinic.com/synthetic-cannabinoid-parkinsons-trial-ser-252-funding/), one that activates the [CB1 receptor](https://cedclinic.com/aelis-farma-financial-results-2025-outlook/) and one that blocks this receptor. [CB1 receptor](https://cedclinic.com/aelis-farma-financial-results-2025-outlook/) is a major biological target bound to and activated by many cannabinoids, including THC and CBD from cannabis. These compounds were tested on a breast cancer cell line known to be aggressive and a population of breast cancer stem cells. The researchers found that although neither compounds reduce cancer cell proliferation, the activator of CB1 significantly inhibits the invasiveness of both cancer cells and cancer stem cells. In contrast, the blocker of CB1 significantly accelerates their ability to migrate and invade. This finding is encouraging, as it indicates that cannabinoids may interfere with not only aggressive cancer cells, but also invasive breast cancer stem cells and therefore can aid cancer eradication. [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoids: A new hope for breast cancer therapy?](https://cedclinic.com/cannabinoids-breast-cancer-research/) An overview of cannabinoids as emerging agents in [breast cancer treatment](https://cedclinic.com/cannabinoids-breast-cancer-research/), exploring their therapeutic potential and mechanisms. [Read More](https://cedclinic.com/cannabinoids-breast-cancer-research/) [Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials](https://cedclinic.com/cannabinoid-treatments-rheumatic-diseases-efficacy-safety/) A [systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) assessing cannabinoid treatment safety and efficacy, providing insights relevant to cancer-related inflammation management. [Explore Study](https://cedclinic.com/cannabinoid-treatments-rheumatic-diseases-efficacy-safety/) [Distinct Effects of 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing](https://cedclinic.com/distinct-effects-tetrahydrocannabinol-cannabidiol-neural-activation/) Research on [THC and CBD effects](https://cedclinic.com/cannabis-induced-alterations-platelet-function-study/) on neural pathways, offering foundational knowledge on cannabinoid receptor interactions. [Learn More](https://cedclinic.com/distinct-effects-tetrahydrocannabinol-cannabidiol-neural-activation/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Anti-Invasion%20Effects%20of%20Cannabinoids%20on%20Breast%20Cancer%20Stem%20Cells&url=https%3A%2F%2Fcedclinic.com%2Fcannabinoids-breast-cancer-stem-cells-anti-invasion-effects%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabinoids-breast-cancer-stem-cells-anti-invasion-effects%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Anti-Invasion%20Effects%20of%20Cannabinoids%20on%20Breast%20Cancer%20Stem%20Cells%20https%3A%2F%2Fcedclinic.com%2Fcannabinoids-breast-cancer-stem-cells-anti-invasion-effects%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).